Global Health Investment Fund
Impact investorNew York · 1 people tracked
Find your way into Global Health Investment Fund
Each arrow is one introduction. Sign up to fill in the first one.
Ask Glenn Rockman to introduce you to Curt LaBelle
You →Glenn · together at Global Health Investment Fund →Curt
Sign up to find every way you can get introduced to Global Health Investment Fund
- Your email: who you already know at Global Health Investment Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Global Health Investment Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
GHIC catalyzes the development of technologies to improve human health worldwide, focusing on strengthening global health security and addressing urgent global health challenges such as infectious disease and maternal and child health. Its namesake $108 million social impact fund (GHIF) backed twelve companies developing clinical diagnostics, devices, vaccines, and therapeutics targeting diseases that disproportionately affect low- and middle-income countries, including HIV/AIDS, malaria, tuberculosis, and cholera. In partnership with BARDA, GHIC uses venture capital investments to support technologies that respond to or prevent public health emergencies like pandemics, working alongside foundations, corporations, nonprofits, and governmental agencies.
Source: firm website, verified Sep 27, 2026.
Team · 1 people
from public directoriesFounder mafia
2 people who came through Global Health Investment Fund went on to found or lead other companies.
What they invest in
from 5 of 7 portfolio companiesHealthtech ×5Biotech ×2Medical Devices ×2Deep Tech ×1FemTech ×1
HQs:United States×5
Investments · 7 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 22022 · 12019 · 12018 · 12017 · 17 dated
Alydia Health manufactures the JADA System, an intrauterine device that uses low-level vacuum to control postpartum hemorrhage in hospital settings.
HealthtechMedical Devices
Co-investorsAstiaAvestria VenturesGlobal Health Investment Corporation
HealthtechReno, US
Tsontcho Ianchulev(Executive Officer, Director)Charles Warden(Director)Brian Walsh(Executive Officer, Director)Bruce J. Brumfield, Jr.(Director)Glenn Rockman(Director)inJim Mazzo(Director)
Co-investorsGlobal Health Investment CorporationVisionary VenturesVisionary Venture
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening.
FemTechHealthtechMedical DevicesMountain View, US
Donald Lee(Executive Officer)inAmelia Degenkolb(Executive Officer, Director)in
BoardLilly DeSouza Burr(Director)Curt LaBelle(Director)Rebecca Shmukler(Director)inShacey Petrovic(Director)in
Co-investorsAvestria VenturesForeground CapitalLaerdal Million Lives FundTullis Health Investors
Ophirex is a biotech company developing varespladib, an investigational oral capsule intended to treat snakebite envenomation by inactivating a key venom toxin found in most snake species.
BiotechDeep TechHealthtechCorte Madera, US
Jerry Harrison(Co-founder; Director)Matthew R. Lewin(Founder and Board Member)inJeremy Gowler(Chief Executive Officer & Board Director)inSara Carter(Executive)Timothy Platts-Mills(Executive)Dotson(Finance leader (Controller/Finance))
Co-investorsTullis Health Investors
Themis offers lending backed by non-fungible tokens, allowing holders to deposit an NFT as collateral and borrow against it.
Neepa Patel(Founder)in
Co-investorsGhaf Capital PartnersLD CapitalNFXAdjuvant CapitalFelicis VenturesHadean Ventures+2 more
Vedanta Biosciences is a clinical-stage biotech developing Live Biotherapeutic Products (LBP) based on defined consortia of bacteria to treat serious gastrointestinal diseases, with an initial focus on preventing recurrent Clostridium difficile infection.
BiotechHealthtechCambridge, US
Bernat Olle(Executive Officer, Director)inDaniel Couto(Executive Officer)inMark Mullikin(Executive Officer)inJeffrey Silber(Executive Officer)inChristopher Viehbacher(Director)
BoardJohn LaMattina(Director)in
Co-investorsAMR Action FundColorcon VenturesK2 HealthVenturesSalica InvestmentsSeventure PartnersBNP Paribas+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Epion Therapeutics
Portfolio news
latest coverage across their companiesVedanta Biosciences · finsmes.com · Aug 6, 2026
Frequently asked questions
- How many investments has Global Health Investment Fund made?
- Global Health Investment Fund has 7 tracked investments.
- What sectors does Global Health Investment Fund focus on?
- Global Health Investment Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Fund located?
- Global Health Investment Fund is headquartered in New York, US.
Media · Podcasts & interviews
featuring the teamInterview with Curt LaBelle, Global Health Investment Fund
IPEM · Curt LaBelle
Co-investors · 2
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.
Laerdal Million Lives Fund is an investor focused on health technology companies.
Firms observed investing alongside Global Health Investment Fund, from public investor directories. Shared companies are the overlap with Global Health Investment Fund's recorded portfolio.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.
EMV Capital is a deep tech and life sciences venture capital investment group that invests in, strengthens, and manages early-stage companies with attractive intellectual property. It uses a capital-efficient model combining syndicated investments, balance sheet stakes, and fund deployment.
Asabys Partners is an investment firm based in Barcelona focused on healthcare and life-sciences innovation.














.jpg)














